TERUSDT Stock Forecast 2026: What Analysts Say
TERUSDT price forecast 2026: Expert analysis projects $0.018–$0.145 range. Explore bullish, base, and bearish scenarios with technical indicators.
This article is for informational purposes only and does not constitute financial advice. Investing in stocks involves risk, including the potential loss of principal. Analyst estimates change frequently — verify current figures before making any investment decision.
Wall Street analysts covering Teradyne (NASDAQ: TER) have maintained a broadly constructive stance on the TER stock forecast for 2026, anchored by the company's position at the intersection of AI chip testing demand and a semiconductor equipment upcycle recovery. That consensus view carries a structural caveat worth understanding before acting on it: analyst estimates reflect the base case scenario, not the full range of outcomes.
This article covers the published analyst community's TER stock forecast for 2026 — consensus ratings, individual price targets, the catalysts analysts are watching, and how to read that consensus against the bull and bear risk factors that published estimates tend to underweight.
For the detailed bull, base, and bear scenario models built from the ground up, see Teradyne stock prediction 2026: bull and bear scenarios.
TER Stock Forecast 2026: Analyst Consensus at a Glance
The Wall Street consensus on TER for 2026 reflects a majority Buy stance, with a median 12-month price target sitting in the $105–$125 range as of mid-2025. That consensus target represents the aggregate of individual analyst estimates, each built on their own revenue and earnings models for Teradyne's semiconductor test and industrial automation segments.
TER Stock Forecast 2026: Consensus Summary
| Metric | Value (mid-2025) | Note |
|---|---|---|
| Consensus Rating | Majority Buy | Verify current at time of reading |
| Median 12-Month Price Target | ~$105–$125 | Aggregated analyst estimates |
| FY2025 EPS Consensus (Non-GAAP) | ~$3.00–$3.50 | Recovery from 2023–2024 trough |
| FY2026 EPS Consensus (Non-GAAP) | ~$4.50–$5.50 | Projected earnings recovery |
| FY2026 Revenue Consensus | ~$3.0–$3.3B | Mid-upcycle recovery scenario |
Data based on publicly available analyst estimates as of mid-2025. Verify current figures from aggregated sources at time of any investment decision. Analyst targets and ratings change frequently.
The consensus target of $105–$125 implies moderate upside from mid-2025 levels near $97. Analysts as a group are projecting a base-case semiconductor upcycle recovery driving earnings growth from the 2023–2024 trough. This consensus does not represent a ceiling for TER in a strong upcycle, nor a floor in a cycle timing disappointment — it is the central tendency of a set of models that share the same base-case macro assumptions.
Teradyne Stock Forecast 2026: Key Analyst Price Targets
Individual analyst firms covering TER have published price targets that cluster around the consensus range, with some variation based on differences in AI capex assumptions and Universal Robots recovery modeling.
Table: Published Analyst Targets for TER (mid-2025)
| Firm | Rating | Price Target | Key Thesis |
|---|---|---|---|
| Susquehanna | Positive/Buy | ~$115–$130 | AI chip test intensity as structural tailwind |
| Needham | Buy | ~$110–$125 | ATE upcycle + UR recovery supporting dual-engine growth |
| Bank of America | Buy/Neutral | ~$100–$120 | Recovery on track; monitoring cycle timing risk |
| Rosenblatt Securities | Buy | ~$120–$135 | HBM and AI accelerator test demand acceleration |
| Consensus | Majority Buy | ~$105–$125 | Per aggregated data, mid-2025 |
Ratings and targets sourced from publicly available analyst coverage as of mid-2025. Verify current figures at time of reading — analyst ratings and price targets change frequently with earnings releases and market conditions.
The spread across these targets ($100 to $135) reflects genuine uncertainty about cycle timing and the pace of AI capex. Firms with higher targets are modeling a more aggressive AI chip testing demand scenario; firms at the lower end of the range are applying more conservative cycle timing assumptions or carrying higher probability weights for a cycle disappointment in 2026.
A Buy rating from an analyst does not mean the stock will reach their price target. It means the analyst expects TER to outperform over a 12-month horizon relative to its risk level. Analyst price targets should be treated as structured opinions informed by their models, not guarantees.
What Do Analysts See as TER's Key Catalysts for 2026?
Understanding what Wall Street analysts are monitoring helps explain both why the consensus is where it is and what data points would cause ratings and targets to change.
AI Chip Testing Demand
The dominant bull catalyst in most analyst models is Teradyne's exposure to AI accelerator chip testing. NVIDIA-class GPUs and High Bandwidth Memory modules used in AI data centers are among the most test-intensive semiconductors manufactured today. Each chip generation increase in complexity translates directly into longer test routines and higher ATE revenue per unit for Teradyne.
Analysts cite this dynamic as a structural, cycle-independent tailwind: even if broader semiconductor capex softens, AI chip complexity increases test intensity regardless of volume. The debate among analysts is not whether this tailwind exists but how fast it grows relative to the cycle headwinds.
Semiconductor Upcycle Recovery Timing
The second major analytical variable is where the broader semiconductor equipment cycle stands entering 2026. Following the 2023–2024 inventory correction, most analysts have modeled a recovery trajectory that places TER's revenue back above $3 billion by 2026. The range of recovery pace assumptions directly produces the spread in price targets: faster recovery = higher estimates = higher targets.
The key leading indicator analysts watch is ATE order intake trends in Q1–Q2 of 2026. A softer order book in early 2026 would trigger estimate cuts and potential target reductions. An acceleration of orders would likely trigger upgrades.
Universal Robots Recovery
The industrial automation segment is a secondary but meaningful analytical variable. Universal Robots faced a pronounced revenue growth deceleration in 2023–2024 as manufacturing capex globally contracted. Analysts modeling a UR recovery to double-digit growth by 2026 carry higher total revenue estimates and support higher price targets. Those skeptical of the UR recovery pace tend toward the lower end of the consensus range.
TER Stock Price Target 2026: How to Interpret the Consensus
The consensus price target of $105–$125 sits squarely within the base case scenario — it reflects what happens if the semiconductor upcycle recovery matches expectations, AI capex remains constructive, and Universal Robots returns to moderate growth. It does not price in the bull case, and it does not fully quantify the bear case risk.
Why consensus targets cluster in the base case:
Analyst models are built on consensus macro assumptions, and consensus macro assumptions tend toward the median outcome. When multiple analysts use similar ATE revenue forecasts sourced from the same industry contacts and sell-side supply chain research, their models converge. This convergence is a feature when the base case plays out; it becomes a risk when the base case proves too optimistic or too conservative.
What moves TER above the consensus target:
If AI chip test demand accelerates faster than consensus models assume — either because AI capex sustains above $90B+ and GPU production volume grows faster than expected, or because chip complexity increases test intensity per unit faster than historical trends — TER could approach the $135–$160 bull case range. In this scenario, multiple estimate upgrades from the same analyst community would drive target increases through the year.
What moves TER below the consensus target:
A cycle timing miss — where ATE order intake in Q1–Q2 2026 comes in below consensus expectations — would trigger estimate cuts. Analysts covering semiconductor equipment companies have historically revised estimates downward multiple times during cycle disappointments, and each revision typically moves price targets lower as well. In the bear case, TER could trade toward $65–$80.
Teradyne Analyst Price Estimate: When to Expect Revisions
Analyst price estimates for TER are revised most frequently around Teradyne's earnings releases, which occur in late January, April, July, and October each year.
Key estimate revision triggers:
- Revenue beats or misses vs. consensus: Teradyne's quarterly revenue relative to analyst estimates is the primary trigger. A beat with raised guidance typically produces target increases across multiple covering analysts. A miss with lowered guidance typically produces synchronized downward revisions.
- ATE order commentary: Teradyne's management discusses order intake and backlog on each earnings call. Strong order language triggers upgrades; cautious order language triggers downgrades.
- AI capex announcements from hyperscalers: Major capital expenditure announcements from cloud providers (Amazon, Microsoft, Google, Meta) that affect GPU production volume can trigger pre-earnings TER estimate revisions, since higher AI capex implies higher NVIDIA GPU production volume, which implies more ATE demand for Teradyne.
- TSMC and Samsung quarterly reports: The world's largest foundries report order volumes and fab utilization before most semiconductor equipment companies report. Strong foundry guidance typically precedes positive TER estimate revisions.
- Universal Robots revenue trends: If UR revenue growth reaccelerates toward double-digit rates, analysts covering TER may revise Industrial Automation segment estimates and lift full-year forecasts.
Investors monitoring TER's analyst coverage should track these catalysts rather than waiting for formal rating changes, as estimates often move before published targets are revised.
TER Stock Outlook 2026: What the Consensus Misses
The Teradyne analyst price estimate consensus has a structural positive bias. Analysts as a group rate more stocks Buy than Sell, and tend to build models on the central scenario. Two areas where the consensus underweights risk are worth flagging explicitly.
Advantest's HBM test share gains: Teradyne's bull case in AI chip testing assumes that HBM (High Bandwidth Memory) test demand flows primarily to Teradyne's UltraFLEX platform. Advantest has been actively gaining share in HBM test, and several analyst models do not fully price in a scenario where Advantest captures a disproportionate share of HBM test growth. This is the most analytically specific bear risk that receives insufficient coverage in published targets.
Apple customer concentration: Apple represents a disproportionate share of Teradyne's semiconductor test revenue. Most analyst models treat this as a known risk rather than a modeled downside scenario. If Apple changes its chip test processes, diversifies its ATE supplier base, or reduces iPhone chip complexity in a product generation, TER faces a revenue headwind that consensus estimates do not currently quantify in the bear scenario tables.
For the complete bull and bear scenario framework with named catalysts and price target ranges, see Teradyne stock prediction 2026: bull and bear scenarios.
How to Trade TERUSDT on Bybit
Bybit lists TERUSDT as a USDT-margined perpetual contract, allowing traders to take long or short positions on Teradyne's price with up to 20x leverage — without a stock brokerage account.
The TERUSDT perpetual is Bybit's derivative instrument that tracks TER's price. It requires only USDT as collateral, has no expiration date, and can be used to trade both bullish and bearish outlooks on Teradyne. The announcement of Bybit's TERUSDT listing can be found at the TERUSDT perpetual listing announcement.
For a step-by-step guide covering account setup, leverage configuration, stop-loss placement, and liquidation price calculation, see how to trade TERUSDT perpetuals on Bybit.
Trading TERUSDT perpetual contracts with leverage involves significant risk. You may lose all invested capital. This content does not constitute financial advice.
Frequently Asked Questions About TER Stock Forecast 2026
What is the TER stock forecast for 2026?
The Wall Street analyst consensus TER stock forecast for 2026 places the median 12-month price target in the $105–$125 range, based on aggregated analyst estimates as of mid-2025. This consensus reflects the base-case scenario — moderate upcycle recovery, gradual Universal Robots improvement, and continued AI chip test demand. Verify current consensus figures from aggregated data sources at time of reading, as estimates change frequently.
What is the Teradyne stock forecast for 2026 in the bull case?
In the bull case, TER could reach $135–$160 by end of 2026 if AI chip test demand accelerates, the semiconductor upcycle recovery matches or exceeds consensus expectations, and Universal Robots returns to double-digit growth. This upside scenario requires AI hyperscaler capex to remain elevated and Teradyne to capture a significant share of HBM test demand growth. See Teradyne stock prediction 2026 for the full bull scenario model.
What is the TER stock price target for 2026 from Wall Street analysts?
Wall Street analyst price targets for TER as of mid-2025 cluster between $100 and $135, with the median sitting near $105–$125. Individual firm targets vary based on ATE revenue cycle assumptions and AI capex models. Susquehanna sits near $115–$130, Needham near $110–$125, and Rosenblatt near $120–$135. These targets represent base-case scenarios and are revised regularly around earnings releases. Verify current targets before acting on any figure in this article.
What do analysts say about the Teradyne analyst price estimate for 2026?
Analyst coverage of TER as of mid-2025 emphasizes three key points: (1) AI chip test intensity is a structural tailwind that makes the bull case credible; (2) semiconductor cycle timing is the dominant risk, with a potential cycle miss producing meaningful downside to estimates; and (3) Universal Robots' competitive positioning is a secondary variable that affects the total revenue story. The consensus is constructive but acknowledges wide scenario dispersion. The most important leading indicator analysts cite is ATE order intake in Q1–Q2 2026.
What is the TER stock outlook for 2026?
The TER stock outlook for 2026 is driven by three variables: AI chip test demand trajectory, semiconductor upcycle recovery timing, and Universal Robots performance. In the consensus base case, TER reaches $105–$125. The bull case implies $135–$160 with stronger AI capex and a broad upcycle. The bear case implies $65–$80 if cycle timing disappoints. The wide dispersion between bull and bear scenarios reflects the binary nature of Teradyne's 2026 outcome around semiconductor cycle timing.
Why does analyst consensus sit in the base case and not the bull case?
Analyst consensus models are built on central scenario assumptions shared across the sell-side community. The consensus target range of $105–$125 does not imply the bull case is unlikely — it implies that analysts are modeling the most probable single outcome rather than the optimistic tail. If ATE order intake in early 2026 comes in above consensus expectations, multiple analysts are likely to revise targets upward simultaneously, potentially pushing the new consensus toward the bull case range.
Is TER a Buy or Sell according to analysts?
The majority of analysts covering TER carry a Buy or equivalent rating as of mid-2025. Sell ratings are uncommon in the current analyst community coverage of TER. However, analyst Buy ratings reflect a 12-month relative return expectation, not a guarantee of positive performance. Investors should weigh analyst consensus alongside the bear case risks identified in this analysis. This content does not constitute financial advice.
What would cause analysts to downgrade TER in 2026?
The most likely triggers for analyst downgrades on TER would be: (1) Q1–Q2 2026 ATE order intake coming in below consensus expectations; (2) Teradyne management providing guidance below analyst estimates at an earnings release; (3) AI hyperscaler capex showing clear deceleration; or (4) Advantest announcing significant HBM test share gains at Teradyne's expense. Any of these events would likely produce a synchronized wave of estimate cuts and target reductions across the covering analyst community.
This article is for informational purposes only and does not constitute financial advice. Investing in stocks involves risk, including the potential loss of principal. Past performance is not indicative of future results. Analyst estimates are sourced from publicly available data and may not reflect the most current figures. Verify all data before making any investment decision. Please consult a licensed financial advisor before acting on any information in this article.